ea0041ep602 | Endocrine tumours and neoplasia | ECE2016
Nolting Svenja
, Prada Elke Tatjana Aristizabal
, Lauseker Michael
, Maurer Julian
, Spottl Gerald
, Goke Burkhard
, Pacak Karel
, Grossman Ashley
Introduction: In our previous studies we found that the combination of 13-cis retinoic acid (13cRA) and lovastatin significantly reduced tumour growth in a mouse phaeochromocytoma allograft model, with the lowest microvessel density in the combination-treated tumours. We have now investigated the effect of 13cRA plus lovastatin on neuroendocrine (BON1, H727) and non-endocrine tumour (HepG2, Huh7) cell viability and signalling pathways (EGFR, AKT, ERK, p70S6K) to eluci...